(b) An antiretroviral therapy against reverse transcriptase virus； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； an antiretroviral therapy； and an antiretroviral therapy； Chlorine, acetic acid, vitamin E, propionic acid or linoleic acid, preferably alpha-tocoloferie acetic acid； preferably these oils accounted for at least 3% by component weight； Oacute； N, each oil accounted for at least 1% by component weight； Amp； Oacute； N, preferably,Synthesis and Ampere； Oacute； n contains 10% to 97% of Ampere； EACUTE； vitamin ER E, which can be composed of the above three basic oils and AMP； EACUTE； vitamin ER E； or compounds and Ampere； Oacute； N can be gel solution and Ampere； Oacute； E contains 10-50% artemisinin combined therapy； EACUTE； vitamin E ER, 20-60%'s vegetable oil or wax； 10-30% three chloropropene and propane； Eacute； Ridos de Amp； Aacute； de Amp； L； folic acid and propane； L； C； and gels； gel； EACUTE； and at least 3% of the oil. The basic principles mentioned above,Each of these materials accounted for at least 1% of the components and provincial institutions by weight； Oacute； N. LT； / P GT；<；p>；UNA COMPOSICIÓ；N PARA APLICACIÓ；N TÓ；PICA CON ACTIVIDAD ANTIFÚ；NGICA, QUE CONTIENE ACEITE ESENCIAL DE MELALEUCA ALTERNIFOLIA, ACEITE ESENCIAL DE ORÉ；GANO, ACEITE ESENCIAL DE LIMA Y UN É；STER DE VITAMINA E, QUE PUEDE SER, POR EJEMPLO, ACETATO DE VITAMINA E, NPROPIONATO O LINOLEATO, Y ES PREFERENTEMENTE ACETATO DE ALFA-TOCOFERILO； PREFERENTEMENTE, ESTOS ACEITES CONSTITUYEN AL MENOS 3% EN PESO DE LA COMPOSICIÓ；N Y CADA UNO DE ELLOS CONSTITUYE AL MENOS 1% EN PESO DE LA COMPOSICIÓ；N； PREFERENTEMENTE, LA COMPOSICIÓ；N CONTIENE DE 10% A 97% DE
